Company Filing History:
4 out of 721 
2 out of 378 
Years Active: 2014-2019
Title: Manfred Möwes: Innovator in Pharmaceutical Chemistry
Introduction
Manfred Möwes is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Möwes holds a total of six patents, with his latest inventions focusing on benzyl substituted indazoles as BUB1 inhibitors. These compounds are defined by specific formulas and are intended for use as pharmaceuticals. His work includes substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides, which are designed for the treatment or prophylaxis of diseases such as cancer.
Career Highlights
Throughout his career, Manfred Möwes has worked with notable companies, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His expertise in pharmaceutical innovation has positioned him as a key figure in the industry.
Collaborations
Möwes has collaborated with several professionals in his field, including Ursula Mönning and William Johnston Scott. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Manfred Möwes is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of diseases. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.